SDS

SAFETY
DATA
SHEET
ALKALINITY Indicator
REVISION DATE : 5/27/2015 Page 6 of 10
Component Animal Toxicology
Inhalation LC50 value:
Sodium carbonate
LC50 1 h = 4.6 mg/l Rat
Sodium hydroxide
No data
Product Animal Toxicity
Oral LD50 value:
LD50 Believed to be > 5,000 mg/kg Rat
Dermal LD50 value:
LD50 Believed to be > 2,000 mg/kg Rabbit
Inhalation LC50
value:
No data
Skin Irritation:
Contact would be expected to cause transient redness if not washed off and left on
the skin for an extended period of time., Not considered to be a primary skin
irritant.
Eye Irritation:
Contact would be expected to cause transient redness if not washed out and left in
the eye for an extended period of time., Not considered to be a primary eye irritant.
Acute Toxicity:
There are no known or reported target organ effects from acute exposure.
Subchronic / Chronic
Toxicity:
Not known or reported to cause subchronic or chronic toxicity.
Sodium carbonate
Male rats were exposed to an aerosol of 2% aqueous
solution of this chemical, 4 hr.day, 5 days/week for 3-1/2
months. No effect was observed at a concentration of
10 or 20 mg/cubic meter. At 70 mg/cubic meter weight
gain was decreased and the lungs showed thickening of
the intra-alveolar walls, hyperemia, and lymphoid
infiltration., Repeated or prolonged skin contact with this
product may cause dermatitis and blistering.
Reproductive and
Developmental Toxicity:
Not known or reported to cause reproductive or developmental toxicity.
Sodium carbonate
This chemical has been tested in laboratory animals
and no evidence of teratogenicity was seen.
Mutagenicity:
Not known or reported to be mutagenic.
Sodium carbonate
This product was determined to be non-mutagenic in
the Ames assay. It was also shown to be non-
clastogenic in the chromosomal aberration test.
Sodium hydroxide
This chemical has been shown to be non-mutagenic
based on a battery of assays.
Carcinogenicity:
This product is not known or reported to be carcinogenic by any reference
source including IARC, OSHA, NTP or EPA.
2-[[4-
(Dimethylamino)phenyl]azo]benzoic
The International Agency for Research on Cancer
(IARC) has classified this product or a component of